Market Recap — March 28, 2026
Recap of insider activity, SEC filings, and market-moving news for March 28, 2026.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Amgen's Repatha Slashes Cardiovascular Event Risk by 31% in High-Risk Patients
Meta Commits $135B to AI Infrastructure; Executive Options Target $9.6T Valuation
Incyte's Oral Skin Drug Povorcitinib Delivers Strong Long-Term Symptom Relief in Late-Stage Trials
UPS to Cut Amazon Volume in 2025; EU Contains AWS Cloud Breach
Coinbase Dominates Bitcoin Custody with 982K BTC, Backs CFTC Oversight for Prediction Markets
Morgan Stanley Launches In-House Spot Bitcoin ETF via 16,000 Advisors
Lilly's Taltz-Zepbound Combination Achieves Superior Efficacy in Phase 3b Trial
Biogen's Litifilimab Shows Significant Efficacy in Second Positive Phase 2 Lupus Trial, Bolstering Breakthrough Status
Boston Scientific's EKOS System Shows Superiority in HI-PEITHO Trial for Acute Pulmonary Embolism
WATCHMAN FLX Device Shows Superior Bleeding Protection, Similar Stroke Reduction to Blood Thinners in CHAMPION-AF Trial
Australia LNG Disruptions Persist at Chevron's Key Facilities Post-Narelle
NY Court Orders Syntel to Pay Cognizant $236.9 Million in Favorable Legal Ruling
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Amgen's Repatha Slashes Cardiovascular Event Risk by 31% in High-Risk Patients
Meta Commits $135B to AI Infrastructure; Executive Options Target $9.6T Valuation
Incyte's Oral Skin Drug Povorcitinib Delivers Strong Long-Term Symptom Relief in Late-Stage Trials
UPS to Cut Amazon Volume in 2025; EU Contains AWS Cloud Breach
Coinbase Dominates Bitcoin Custody with 982K BTC, Backs CFTC Oversight for Prediction Markets
Morgan Stanley Launches In-House Spot Bitcoin ETF via 16,000 Advisors
Lilly's Taltz-Zepbound Combination Achieves Superior Efficacy in Phase 3b Trial
Biogen's Litifilimab Shows Significant Efficacy in Second Positive Phase 2 Lupus Trial, Bolstering Breakthrough Status
Boston Scientific's EKOS System Shows Superiority in HI-PEITHO Trial for Acute Pulmonary Embolism
WATCHMAN FLX Device Shows Superior Bleeding Protection, Similar Stroke Reduction to Blood Thinners in CHAMPION-AF Trial
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.